These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22629765)

  • 1. [2nd prize in the competition of young scientists in the XVIII National Congress "Man and Medicine" of 2011].
    Andreev DN
    Eksp Klin Gastroenterol; 2011; (8):102-4. PubMed ID: 22629765
    [No Abstract]   [Full Text] [Related]  

  • 2. [2nd prize in the competition of works in hepatology GSSR 2010 new approaches to treatment of patients with Nash type 2 diabetes].
    V'iuchnova ES; Babina SM
    Eksp Klin Gastroenterol; 2011; (8):91-6. PubMed ID: 22629763
    [No Abstract]   [Full Text] [Related]  

  • 3. [Distribution pattern of traditional Chinese medicine syndromes in 793 patients with fatty liver disease].
    Wei HF; Liu T; Xing LJ; Zheng PY; Ji G
    Zhong Xi Yi Jie He Xue Bao; 2009 May; 7(5):411-7. PubMed ID: 19435553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Waist-to-hip ratio is a superior predictor for non-alcoholic simple fatty liver].
    Jiang L; Chen XW; Zheng RD; Chen J; Meng JR; Xu MY; Qu Y; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):859-61. PubMed ID: 21138638
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of fatty liver with essential phospholipids].
    Arendt R; Nowotny P; Teichmann W
    Z Gesamte Inn Med; 1970 Jul; 25(13):587-9. PubMed ID: 5523267
    [No Abstract]   [Full Text] [Related]  

  • 6. What is the best indicator for evaluating treatment response in nonalcoholic fatty liver disease: histology or aminotransferase levels?
    Akyuz F; Demir K; Cevikbas U; Okten A
    J Gastroenterol Hepatol; 2005 Jan; 20(1):167-8. PubMed ID: 15610470
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy of using alpha-lipoic acid (berlition) in patients with nonalcoholic steatohepatitis].
    Podymova SD; Davletshina IV
    Eksp Klin Gastroenterol; 2008; (5):77-84. PubMed ID: 19148996
    [No Abstract]   [Full Text] [Related]  

  • 8. [Disorders of the liver detoxicating function in 536 histologically diagnosed fatty liver patients].
    Korn U; Fischer R; Müting D
    Verh Dtsch Ges Inn Med; 1972; 78():1386-9. PubMed ID: 4665554
    [No Abstract]   [Full Text] [Related]  

  • 9. The add-on effects of Gynostemma pentaphyllum on nonalcoholic fatty liver disease.
    Chou SC; Chen KW; Hwang JS; Lu WT; Chu YY; Lin JD; Chang HJ; See LC
    Altern Ther Health Med; 2006; 12(3):34-9. PubMed ID: 16708768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of Yiqi Sanju Formula on non-alcoholic fatty liver disease: a randomized controlled trial].
    Lou SY; Liu Y; Ma YY; Chen HY; Chen WH; Ying J; He YM; Wang WJ
    Zhong Xi Yi Jie He Xue Bao; 2008 Aug; 6(8):793-8. PubMed ID: 18664346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of Qushi Huayu Decoction in prevention and treatment of fatty liver in rats based on adiponectin-free fatty acid pathway].
    Li HS; Feng Q; Xu LL; Chen SD; Li XM; Hu YY
    Zhong Xi Yi Jie He Xue Bao; 2009 Jun; 7(6):546-51. PubMed ID: 19583937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The antisteatosic activity of 2-MPG (Thiola). Study with the (BSF) dynamic test and with liver biopsy before and after the treatment].
    Surrenti C; Arcangeli A; Casini A
    Minerva Med; 1978 Dec; 69(61):4251-6. PubMed ID: 733081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute fatty metamorphosis of the liver and pregnancy. A case report].
    Jasso Aranda R; Alcalá Jiménez F; Terán MJ; Cortés Pérez J
    Ginecol Obstet Mex; 1977 Sep; 42(251):207-14. PubMed ID: 401384
    [No Abstract]   [Full Text] [Related]  

  • 14. [Glutathione in the treatment of chronic fatty liver diseases].
    Dentico P; Volpe A; Buongiorno R; Grattagliano I; Altomare E; Tantimonaco G; Scotto G; Sacco R; Schiraldi O
    Recenti Prog Med; 1995; 86(7-8):290-3. PubMed ID: 7569285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcohol induced steatohepatitis in non-obese patients: treatment with ursodeoxycholic acid.
    Bauditz J; Schmidt HH; Dippe P; Lochs H; Pirlich M
    Am J Gastroenterol; 2004 May; 99(5):959-60. PubMed ID: 15128373
    [No Abstract]   [Full Text] [Related]  

  • 16. [Efficacy comparison between bicyclol and polyene phosphatidylcholine treatments for the patients with nonalcoholic fatty liver disease].
    Su HL; Zhu YX; Gao ZJ; Dong XY; Zhu JY; Lei WR; Zhang Y; Han Y
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jul; 19(7):552-3. PubMed ID: 22152250
    [No Abstract]   [Full Text] [Related]  

  • 17. [The functional condition of the hepato-biliary system in fatty hepatosis with concomitant diabetes mellitus].
    Suchkova EV
    Eksp Klin Gastroenterol; 2009; (8):26-9. PubMed ID: 20469675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Taurine in the treatment of non-alcoholic fatty liver disease].
    Zvenigorodskaia LA; Ovsiannikova ON; Noskova KK; Nilova TV; Elizarova EP
    Eksp Klin Gastroenterol; 2010; (7):43-50. PubMed ID: 21033082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-alcoholic fatty liver disease: age peculiarities, breakthrough in pathogenetic therapy].
    Pal'tsev AI; Sharapov IV; Gorbunova EN; Khomchenko TN; Kurganova IV; Soldatova GS; Eremina AA; Nikolaev IuA
    Eksp Klin Gastroenterol; 2009; (8):19-25. PubMed ID: 20469674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic steatohepatitis: role of leptin in pathogenesis and benefits of metformin in treatment.
    Kadayifçi A
    Am J Gastroenterol; 2003 Oct; 98(10):2330; author reply 2330-1. PubMed ID: 14572592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.